Top Medical Technologies Startups in 2027

Tombot makes robotic animals that transform the daily life of individuals, families and communities facing health adversities. Originally designed to meet the specific medical needs of seniors with dementia, Tombot Puppies have also been preordered for children with Autism, adults with high impact chronic pain, major depressive disorder, anxiety, bipolar disorder, and PTSD, and for long inpatient stays and arduous outpatient treatments at hospitals. Peer-reviewed studies show that robotic animals positively affect some users’ ability to cope with stress, anxiety, loneliness, depression and pain, reducing their need for psychotropic and opioid medications. Key Milestones and Metrics: • Completion of our 5th generation prototype and 3rd round of customers studies with 100s of seniors with dementia • Over 3,900 preorder and waitlist customers • Member of StartX: Stanford-funded startup accelerator program • Member of the Canadian Creative Destruction Lab accelerator program • Member of Children’s Hospital of Los Angeles accelerator program (CTIP) • Large-scale clinical trials in development with Children’s Hospital and the University of Southern California to demonstrate reduced stress, anxiety and pain for pediatric hospital inpatients • Large scale study in development with the LAC-USC Hospital Burn Unit to demonstrate reduced stress, anxiety, and pain for pediatric burn patients • Major national and international media coverage • Winner 2019 RoboBusiness Pitchfire competition • Filed multiple trademark, design and provisional utility patent applications • U.S. TAM: $9.0B (seniors with dementia plus mild cognitive impairment)

We develop cutting edge medical devices that leverage machine learning and artificial intelligence for healthcare.

AMBOSS is a powerful learning and clinical decision support tool striving to empower physicians across the globe to provide the best possible care. Since our launch in 2012, we've used cutting-edge technology to revolutionize the way physicians and trainees acquire and apply the latest in scientific knowledge, thereby benefiting patients everywhere. By 2017, we transformed the learning experience for 95% of the German market and launched our international platform. In 2019, our hard work secured €30M in Series B funding to expand our products and their reach. Today, we continue to find new ways to innovate and establish ourselves to make a global impact. After being named a Top 10 Health & Science company to watch in 2021 by Business Punk, it is clear that we are not the only ones who are excited about the future of AMBOSS.

The Cedars-Sinai Accelerator is transforming healthcare quality, efficiency, and care delivery by helping entrepreneurs bring their innovative technology products to market. This three-month program, based in Los Angeles, California, provides companies with $100,000 in funding, mentorship from more than 300 leading clinicians and executives, access to Cedars-Sinai, and exposure to a broad network of entrepreneurs and investors. Since 2015, the accelerator has helped dozens of companies transform healthcare delivery and patient care.

Our evidence-based program provides a safe and effective alternative to traditional 12-step based approaches and includes physician managed treatment with FDA approved medications, individual coaching, at-home progress tracking, and family and social support through our mobile app. Hundreds of members have joined the Ria Health program and achieved their goals of reducing their drinking and improving their overall health and wellness.

Our mission is to create simple, effective, affordable, and empowering vestibular technologies. Our goal is to improve the accuracy of research, assessment, treatment, and training of vestibular care as provided by healthcare professionals and educators within inpatient, outpatient, and academic settings across the world. Our patent-pending technology combined with our innovative educational programs will measurably improve the patient experience by reducing or eliminating unnecessary medical specialist visits, medication, and prolonged symptoms that can affect patient’s ability to work and perform daily activities safely.

DeepSight™ Technology is revolutionizing diagnostic medical imaging by taking the safest, fastest, most affordable, and most accessible imaging modality and delivering a quantum leap in performance.

Sonio offers real-time, cloud-based diagnostic support software based on multiple data. Created by a team of scientific and medical experts, Sonio relies on continuous research and development to regularly incorporate new technological bricks into its software. We're selling our products to doctors that are doing ultrasound on pregnant women. It brings them both medical and productivity value.

AI Eyes for Every Doctor. At DocGlasses (Vision Health Holdings Inc., USA), we are pioneering a global first for healthcare: AI-powered smart glasses that see, hear, and assist medical professionals in real time—automatically. Our mission is to bridge the gap between complex digital medical records and hands-free, patient-centric clinical care. Our Technology DocGlasses utilizes a patent-pending Vision AI engine that simultaneously processes live consultation audio, patient history, and medical records (like X-rays and lab results). Directly within the doctor’s line of sight, our smart glasses suggest diagnoses, offer triage questions, and automatically draft structured clinical notes to the EHR. By eliminating the need to type and toggle between screens, doctors can focus entirely on what matters most: the patient. Scientifically Validated & Trusted Our vision-enabled AI scribe architecture has been independently validated in npj Digital Medicine (2026) in partnership with Flinders University, Australia. During clinical testing, our technology achieved 98% accuracy—drastically reducing omission errors by 35× compared to standard audio-only clinical scribes. Our Impact Whether in busy public clinics, during home nurse visits, or in emergency paramedic routing, DocGlasses improves clinical standards uniformly. In addition to aiding doctors, we empower public healthcare systems with state-level quality dashboards, live data monitoring, and continuing education tools. Guided by Experts Founded by Danish Ahmed (CEO) and built by a global team of technology, healthcare, and AI pioneers, DocGlasses is backed by world-class partners like Qualcomm, NVIDIA, AWS, and Google Cloud. Fully compliant with HIPAA, GDPR, and DPDP, we are transforming the frontline of medical care with trust, security, and world-class innovation.